EUVIMEDEUVIMED entdecken
Kohortenstudie

AB033. Oncological outcome following CAP-like versus alternative induction chemotherapy for locally advanced thymic epithelial tumors: a 30-year single-center retrospective cohort study

Fleur Valgaeren, Charlotte Schoenaers, Cedric Vanluyten, Ewout Muylle, Maarten Lambrecht, Dirk E. Van Raemdonck, Laurens J. Ceulemans, Lori M. van Roozendaal, Paul M. J. Clement

Mediastinum · 2026-10 · 10 · AB033-AB033

DOI: 10.21037/med-26-ab033 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Mediastinum, 2026-10. Verfasst von Fleur Valgaeren und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Valgaeren, F., Schoenaers, C., Vanluyten, C., Muylle, E., Lambrecht, M., Raemdonck, D. E. V., Ceulemans, L. J., Roozendaal, L. M. V., & Clement, P. M. J. (2026). AB033. Oncological outcome following CAP-like versus alternative induction chemotherapy for locally advanced thymic epithelial tumors: a 30-year single-center retrospective cohort study. Mediastinum, 10, AB033-AB033. https://doi.org/10.21037/med-26-ab033

Vancouver

Valgaeren F, Schoenaers C, Vanluyten C, Muylle E, Lambrecht M, Raemdonck DEV, et al. AB033. Oncological outcome following CAP-like versus alternative induction chemotherapy for locally advanced thymic epithelial tumors: a 30-year single-center retrospective cohort study. Mediastinum. 2026;10:AB033-AB033. doi:10.21037/med-26-ab033

BibTeX
@article{Valgaeren2026,
  author = {Valgaeren, Fleur and Schoenaers, Charlotte and Vanluyten, Cedric and Muylle, Ewout and Lambrecht, Maarten and Raemdonck, Dirk E. Van and Ceulemans, Laurens J. and Roozendaal, Lori M. van and Clement, Paul M. J.},
  title = {AB033. Oncological outcome following CAP-like versus alternative induction chemotherapy for locally advanced thymic epithelial tumors: a 30-year single-center retrospective cohort study},
  journal = {Mediastinum},
  year = {2026},
  volume = {10},
  pages = {AB033--AB033},
  doi = {10.21037/med-26-ab033}
}
Kostenlos starten →